FDA
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
FDA
May 8, 2024, 01:30 |
Blog
Mel Mann: Career switch during a terminal illness
Mel Mann, Patient Advocate in Oncology and cancer survivor, shared on X/Twitter: "CAREER SWITCH DURING A…
May 7, 2024, 11:33 |
Blog
Douglas Flora: The research you’ve performed, and published is changing the way cancer patients are treated around the world
Douglas Flora shared a post by Jaime Grund, Director of St. Elizabeth Healthcare, on LinkedIn: "Patients are safer…
May 7, 2024, 04:39 |
Blog
Sinan Sarac: Parexel will be heavily represented at ASCO24
Sinan Sarac, Vice President of Regulatory Strategy at Parexel, shared a post on LinkedIn: "I…
May 5, 2024, 12:26 |
Blog
Albert Bourla: Some highlights from Pfizer’s 2024 Q1 financial results
Albert Bourla, Chairman and Chief Executive Officer at Pfizer, shared a post on LinkedIn: "Today, I…
May 3, 2024, 05:06 |
Opinion
Vincent Rajkumar on the Importance of Accelerated Approval for Cancer Treatment
Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, shared on X: "On Accelerated Approval…
May 3, 2024, 04:43 |
Blog
Wafik El-Deiry: This is very sad to see in 2024 in the US
Karen Knudsen recently shared a post by the American Cancer Society Cancer Action Network on X/Twitter, adding:…
May 2, 2024, 14:43 |
Blog
Wishing everyone a great time, particularly the participants of OncoDaily's party - Advanced Oncology
Advanced Oncology shared a post by Sinan B. Sarac, Vice President of Regulatory Strategy at…
May 2, 2024, 13:23 |
Insight
Marco Donia: Welcoming the Era of Gene Editing in Medicine
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared on LinkedIn: "Autologous…
May 2, 2024, 02:53 |
Drugs
FDA approves lutetium Lu 177 dotatate for pediatric patients 12 years and older with GEP-NETS
FDA Approves the First Radioactive Drug for Pediatric Neuroendocrine Tumors the U.S. Food and Drug…
May 1, 2024, 12:17 |
Insight
David R. Liu: The first prime editing clinical trial has been cleared by U.S. FDA to begin
David R. Liu, Core Institute Member and Vice-Chair of the Faculty at Broad Institute of MIT…
1
2
3
4
5
All:
130
Posts:
1 - 10
Neuroendocrine tumors - newly updated AJCC guidelines
5 min Sarcoma Talk with Shushan Hovsepyan and Andrea Ferrari
OncoInfluencers: Dialogue with Tony Mok, hosted by Gevorg Tamamyan
New Paper Alert! Complete Response with Chemoimmunotherapy in Intrahepatic Cholangiocarcinoma
Vincent Rajkumar on the Importance of Accelerated Approval for Cancer Treatment
Facebook
RSS Feed
Twitter
Linkedin
Youtube